Frequencies of HER-2/neu expression and gene amplification in patients with oesophageal squamous cell carcinoma

The utilisation of antitumour T cells induced by cancer vaccination with HER-2 peptides or antibodies (Herceptin) against HER-2, as immunotherapy for oesophageal cancer, is a novel and attractive approach. It is important to clarify the frequencies of HER-2 expression and gene amplification in patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Mimura, K, Kono, K, Hanawa, M, Mitsui, F, Sugai, H, Miyagawa, N, Ooi, A, Fujii, H
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2005
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361961/
https://www.ncbi.nlm.nih.gov/pubmed/15785739
http://dx.doi.org/10.1038/sj.bjc.6602499

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361961/
https://www.ncbi.nlm.nih.gov/pubmed/15785739
http://dx.doi.org/10.1038/sj.bjc.6602499

Ejemplares similares